Literature DB >> 12185466

Liddle syndrome in a newborn infant.

Farahnak K Assadi1, Robert E Kimura, Uma Subramanian, Sameer Patel.   

Abstract

A 10-week-old female infant developed hypertension. The elevated blood pressure was associated with metabolic alkalosis and urinary chloride wastage. The family history was unremarkable. Her urinalysis, blood urea nitrogen (BUN), and serum creatinine concentrations were all normal. A renal ultrasound was normal. A technetium-99m diethylenetriaminopentoacetic acid (DTPA) renal scan with captopril showed normal blood flow bilaterally. The head ultrasound and echocardiogram were normal. Blood epinephrine, norepinephrine, catecholamines, thyroxine, and steroid levels were also normal. Treatment with various combinations of labetalol, hydralazine, captopril, methyldopa, nifedipine, and spironolactone, all at high doses, failed to control the elevated blood pressure. Serum aldosterone level and peripheral plasma renin activity were low. The lack of therapeutic response to spironolactone, with a good response to amiloride and recurrence of hypertension and metabolic alkalosis after amiloride cessation that was subsequently treated with amiloride, established the diagnosis of Liddle syndrome. To our knowledge, this is the youngest patient with Liddle syndrome that has been reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185466     DOI: 10.1007/s00467-002-0897-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  7 in total

1.  Distinction between Liddle syndrome and apparent mineralocorticoid excess.

Authors:  L Monnens; E Levtchenko
Journal:  Pediatr Nephrol       Date:  2003-11-19       Impact factor: 3.714

2.  The distinction between Liddle syndrome and apparent mineralocorticoid excess.

Authors:  Mario G Bianchetti; Giacomo D Simonetti; Paolo Ferrari
Journal:  Pediatr Nephrol       Date:  2003-01-24       Impact factor: 3.714

Review 3.  Liddle syndrome in a Serbian family and literature review of underlying mutations.

Authors:  Radovan Bogdanović; Vladimir Kuburović; Nataša Stajić; Sadaf S Mughal; Alina Hilger; Sanja Ninić; Sergej Prijić; Michael Ludwig
Journal:  Eur J Pediatr       Date:  2011-09-29       Impact factor: 3.183

4.  A novel epithelial sodium channel beta-subunit mutation associated with hypertensive Liddle syndrome.

Authors:  Michael Freundlich; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2005-02-03       Impact factor: 3.714

5.  Pathogenicity and Long-Term Outcomes of Liddle Syndrome Caused by a Nonsense Mutation of SCNN1G in a Chinese Family.

Authors:  Di Zhang; Yi Qu; Xue-Qi Dong; Yi-Ting Lu; Kun-Qi Yang; Xin-Chang Liu; Peng Fan; Yu-Xiao Hu; Chun-Xue Yang; Ling-Gen Gao; Ya-Xin Liu; Xian-Liang Zhou
Journal:  Front Pediatr       Date:  2022-05-24       Impact factor: 3.569

6.  A case of Liddle Syndrome.

Authors:  Rajiv Sinha; Indrayani Salphale; Indira Agarwal
Journal:  Indian J Pediatr       Date:  2013-01-12       Impact factor: 1.967

7.  Prevalence of Liddle Syndrome Among Young Hypertension Patients of Undetermined Cause in a Chinese Population.

Authors:  Lin-Ping Wang; Kun-Qi Yang; Xiong-Jing Jiang; Hai-Ying Wu; Hui-Min Zhang; Yu-Bao Zou; Lei Song; Jin Bian; Ru-Tai Hui; Ya-Xin Liu; Xian-Liang Zhou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-15       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.